DCM Shriram Consolidated has received a GST demand order from tax authorities, disclosing the development under regulatory compliance requirements. The company informed stock exchanges about the order received from the Assistant Commissioner, Central Goods and Service Tax, Kota, Rajasthan.

GST Demand Details

The tax authority has raised a demand involving significant amounts across multiple components:

Nature of Dispute

The GST demand pertains to the disallowance of Input Tax Credit (ITC) availed on cargo handling and other related services in respect of coal purchases. The authority has disallowed the claimed input tax credit for the period from FY2018-19 to FY2022-23.

Company's Response and Impact

DCM Shriram Consolidated has not provided specific details about its response to the demand order. However, companies typically have the option to challenge such orders through available legal remedies.

Regarding the financial impact, the company faces a tax demand of ₹85.80 lakhs plus applicable interest and penalty. The total impact will depend on the final resolution of the matter.

Regulatory Compliance

The disclosure was made in compliance with regulatory requirements, which mandate listed companies to promptly disclose material events and developments that could impact investor decisions.

DCM Shriram Consolidated has announced the liquidation of its wholly-owned step-down subsidiary, Bioseed Research USA Inc., effective December 15, 2025. The company disclosed this development to the stock exchanges on December 19, 2025, in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Subsidiary Liquidation Details

The liquidation became effective from December 15, 2025, following which Bioseed Research USA Inc. ceased to be a wholly-owned subsidiary of DCM Shriram Consolidated. The company received intimation of the liquidation on December 19, 2025, at approximately 4:00 a.m. IST.

Financial Position

As of March 31, 2025, Bioseed Research USA Inc. maintained a minimal financial footprint with the following position:

The subsidiary had no revenue or income contribution to DCM Shriram Consolidated during the last financial year, indicating limited operational activities.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 read with Para A of Schedule III of SEBI Listing Regulations, 2015. The company also referenced compliance with SEBI Master Circular No. SEBI/HO/CFD/PoD-2/CIR/P/0155 dated November 11, 2024.

Key regulatory aspects include:

• No sale agreement involved as the entity was voluntarily liquidated
• No buyer details applicable due to voluntary liquidation
• No related party transactions involved in the process
• Liquidation subject to necessary tax and accounting filings under local US laws

Corporate Structure Impact

With the liquidation of Bioseed Research USA Inc., DCM Shriram Consolidated's international subsidiary structure has been streamlined. The voluntary nature of the liquidation suggests a strategic decision to optimize the corporate structure and reduce administrative overhead for a non-operational entity.

The liquidation process remains subject to completion of necessary tax and accounting filings by Bioseed Research USA Inc. in accordance with local US laws and regulations.